Research Topics

Sebastian J C Neggers

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. Neggers S, de Herder W, Feelders R, van der Lely A. Conversion of daily pegvisomant to weekly pegvisomant combined with long-acting somatostatin analogs, in controlled acromegaly patients. Pituitary. 2011;14:253-8 pubmed publisher
    ..However, there seems to be a wide variation in the reduction of PEG-V dose, which can be obtained after conversion to combined treatment...
  2. Neggers S, van der Lely A. Combination treatment with somatostatin analogues and pegvisomant in acromegaly. Growth Horm IGF Res. 2011;21:129-33 pubmed publisher
    ..Transient elevations in the levels of transaminases are the main adverse effects of combination treatment, which occur in about 11-15% of patients...
  3. Neggers S, Biermasz N, van der Lely A. What is active acromegaly and which parameters do we have?. Clin Endocrinol (Oxf). 2012;76:609-14 pubmed publisher
    ..Both GH and IGF1 have been associated with prognosis, in particular mortality. In this review, we discuss the available parameters to assess disease activity in acromegaly...

Collaborators

Detail Information

Publications3

  1. Neggers S, de Herder W, Feelders R, van der Lely A. Conversion of daily pegvisomant to weekly pegvisomant combined with long-acting somatostatin analogs, in controlled acromegaly patients. Pituitary. 2011;14:253-8 pubmed publisher
    ..However, there seems to be a wide variation in the reduction of PEG-V dose, which can be obtained after conversion to combined treatment...
  2. Neggers S, van der Lely A. Combination treatment with somatostatin analogues and pegvisomant in acromegaly. Growth Horm IGF Res. 2011;21:129-33 pubmed publisher
    ..Transient elevations in the levels of transaminases are the main adverse effects of combination treatment, which occur in about 11-15% of patients...
  3. Neggers S, Biermasz N, van der Lely A. What is active acromegaly and which parameters do we have?. Clin Endocrinol (Oxf). 2012;76:609-14 pubmed publisher
    ..Both GH and IGF1 have been associated with prognosis, in particular mortality. In this review, we discuss the available parameters to assess disease activity in acromegaly...